Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The BAP has provided a review of the research evidence and clinical experience in the treatment of bipolar disorder. It has produced guidelines that give very real practical advice to clinicians in the day-to-day management of this difficult condition. Its recommended enhancement of routine care may well increase adherence to treatment, especially if the patient is involved in choice of medicine, leading to lower overall morbidity. It is timely since awareness of the specific needs of bipolar patients is growing and there is an increased choice of effective treatments for all phases of the illness.


Journal article


J Psychopharmacol

Publication Date





3 - 6


Antidepressive Agents, Antimanic Agents, Bipolar Disorder, Drug Administration Schedule, Evidence-Based Medicine, Humans, Practice Guidelines as Topic, United Kingdom